Using less invasive, remote specimen collection approaches in these contexts can make things easier. However, older methods of dried capillary blood collection, such as dried blood spot (DBS) cards and filter paper, have limitations (most notably the hematocrit bias). These limitations impede the ability to get specimens that can generate high-quality data of the sort that is needed for research.
Enter Volumetric Absorptive Microsampling, as demonstrated by the Mitra device based on VAMS® technology. VAMS® is making remote specimen collection, including capillary blood collection, easier for vulnerable patient populations and much less intimidating.
Because anyone can use a Mitra® device to collect their own samples with minimal training, VAMS® technology is changing how researchers work with vulnerable populations. Clinical research, clinical trials, and other crucial, lifesaving work has become easier as this smarter blood collection technology has begun to proliferate.